KFDA approves additional indication of Seroquel

Published: 2004-03-05 06:57:00

Updated: 2004-03-05 06:57:00

AstraZeneca Korea said recently it has received from the Korea Food and Drug Administration an additional indication of Seroquel (quetiapine), which is available at 25mg, 100 mg and 200 mg, for the treatment of acute manic episodes associated with bipolar disorder.

Seroquel has been orally indicated for the treatment of psychotic disorders (including schizophrenia) since 1997. During Januar...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.